InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.7501
-0.0120 (-1.57%)
Apr 24, 2026, 11:35 AM EDT - Market open
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$346,661
Profits / Employee
-$589,566
Market Cap
3.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2024 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2023 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2022 | 13 | 1 | 8.33% | 13 | 0 |
| Jun 30, 2021 | 12 | 0 | - | 12 | 0 |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 216 |
| IM Cannabis | 95 |
| China SXT Pharmaceuticals | 75 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| RedHill Biopharma | 35 |
| Sonoma Pharmaceuticals | 8 |
| Gelteq | 8 |
INM News
- 27 days ago - InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance - Newsfile Corp
- 4 weeks ago - InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program - Newsfile Corp
- 6 weeks ago - InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial - Newsfile Corp
- 6 weeks ago - InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - Newsfile Corp
- 2 months ago - InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - Newsfile Corp
- 4 months ago - InMed Announces Results of 2025 Annual General and Special Meeting - Newsfile Corp
- 4 months ago - InMed Provides Update on BayMedica Commercial Business - Newsfile Corp
- 5 months ago - InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 - Newsfile Corp